Summary
ChemImage Corp (ChemImage) is a molecular chemical imaging company that provides hyperspectral imaging technologies. The company develops molecular chemical imaging devices and data fusion tools for anatomic structure imaging, cancer detection and cardiovascular health assessment. It offers various products ranging from molecular chemical imaging filters and liquid crystal tunable optics to dynamic sensors. The company’s products include verovision threat detector that detects chemical, explosives and narcotic residue on stationary objects; and mail screener solution. It also focuses on the development of intraoperative endoscope technology to detect tumor margins and anatomic structures during surgical procedures. The company develops in vitro test that detects colon cancer and pre-cancerous polyps from a dried blood spot. It also develops non-invasive test to detect and quantify peripheral edema levels. It caters to defense, security, pharmaceuticals, forensics and medical device and other industries. ChemImage is headquartered in Pittsburgh, Pennsylvania, the US.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook